Status:
COMPLETED
Corticosteroid Therapy in Refractory Shock Following Cardiac Arrest
Lead Sponsor:
Beth Israel Deaconess Medical Center
Collaborating Sponsors:
American Heart Association
Conditions:
Cardiac Arrest
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
The major goal of this project is to determine whether the use of physiologic doses of corticosteroids will decrease time to shock reversal, alters the inflammatory cascade, and alters microcirculator...
Eligibility Criteria
Inclusion
- Greater than 18 years old
- Either pre-hospital cardiac arrest and ROSC or Inpatient Cardiac Arrest with resultant ROSC
- Vasopressor dependent for a minimum of 1 hour post-arrest
Exclusion
- Pregnant
- Indication for Corticosteroids outside of current research proposal
- DNR or comfort care measures
- Presence of septic shock
- Chronic Use (\>1week) of oral Corticosteroids in the last year
Key Trial Info
Start Date :
October 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2014
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00676585
Start Date
October 1 2007
End Date
April 1 2014
Last Update
May 17 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215